Arax Advisory Partners
HELP

Arax Advisory Partners’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Arax Advisory Partners’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86 Buy
+13
New +$65 ﹤0.01% 5145
2026
Q1 		– Sell
-13
Closed -$106 – 3921
2025
Q4 		$106 Hold
13
– – ﹤0.01% 3819
2025
Q3 		$76 Buy
+13
New +$92 ﹤0.01% 3514
2025
Q2 		– Sell
-6
Closed -$39 – 3078
2025
Q1 		$39 Buy
+6
New +$52 ﹤0.01% 2637

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Arax Advisory Partners's HELP Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Helus Pharma Inc. Common Stock (HELP) in Q2 2026: 13 shares worth $86. The stake represents ﹤0.01% of the portfolio and ranks #5145 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in HELP as recently as Q4 2025.

Arax Advisory Partners first reported a position in HELP in Q1 2025 and has held it in 4 quarters since. The position peaked at $106 in Q4 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Arax Advisory Partners held 13 shares of Helus Pharma Inc. Common Stock worth $86 as of Q2 2026.
  • Helus Pharma Inc. Common Stock was a new Arax Advisory Partners position in Q2 2026.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #5145 holding.
  • Arax Advisory Partners first reported a position in Helus Pharma Inc. Common Stock in Q1 2025 and has held it in 4 quarters since.
  • Arax Advisory Partners's Helus Pharma Inc. Common Stock position peaked at $106 in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.